RecallReported September 23, 2026
Class II recall by SUN PHARMA /TARO
Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist …
FDA's enforcement report of September 23, 2026 lists a Class II recall by SUN PHARMA /TARO of Hawthorne, NY. Product: Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist …. Status: Ongoing.
On the record
- Recalling firm
- SUN PHARMA /TARO
- Location
- Hawthorne, NY
- Classification
- Class II
- Status
- Ongoing
- Recall number
- D-0848-2026
- Product type
- Drugs
- Brand names
- LIDOCAINE
- Generic names
- LIDOCAINE
- Recall initiated
- 2026-08-31
- Reported by FDA
- 2026-09-23
The full record
An account shows the reason for the recall, where the product was distributed and the lots.
What a recall is
FDA classifies a recall by the hazard. Class I: a reasonable probability that the product will cause serious adverse health consequences or death. Class II: the product may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III: the product is not likely to cause adverse health consequences.
More
Watch SUN PHARMA /TARO
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA enforcement reports. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with SUN PHARMA /TARO.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.